Prevención de la enfermedad cardiovascular en adultos con diabetes mellitus tipo 2
Diabetes mellitus is a global public health problem, since it is one of the non-communicable diseases with the greatest presence in humans. There are several types of Diabetes mellitus, among the main ones: type 1 diabetes and type 2 diabetes. Type 2 diabetes is a disability in the way the body regu...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Spanish |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://dialnet.unirioja.es/servlet/oaiart?codigo=8430810 |
| Source: | RECIMUNDO: Revista Científica de la Investigación y el Conocimiento, ISSN 2588-073X, Vol. 6, Nº. 2, 2022, pags. 432-441 |
| Tags: |
Add Tag
No Tags: Be the first to tag this record
|
| Summary: |
Diabetes mellitus is a global public health problem, since it is one of the non-communicable diseases with the greatest presence in humans. There are several types of Diabetes mellitus, among the main ones: type 1 diabetes and type 2 diabetes. Type 2 diabetes is a disability in the way the body regulates and uses the level of sugar (glucose) as fuel. This long-term (chronic) condition increases the circulation of sugar in the bloodstream. Eventually, elevated blood glucose levels can lead to other disorders, including cardiovascular disease. Diabetes is associated with an increased risk of heart disease, stroke, high blood pressure, and narrowing of the blood vessels (atherosclerosis). The purpose of this research is to summarize the most outstanding aspects of the prevention of cardiovascular disease in patients with type 2 diabetes mellitus. The research was carried out under a bibliographic documentary-type methodology, under the review modality. The review shows, first, that there is a high cardiovascular risk in diabetic patients. In this sense, the control of cardiovas-cular risk factors is decisive for the prevention and/or delay of cardiovascular disease. Among the main risk factors were found: lifestyle, obesity, arterial hypertension, glycemic control and lipids. It is essential to improve the cardiometabolic control of patients with type 2 dia-betes mellitus and to reach the therapeutic goals of the greatest possible number of cardiovascular risk factors. Likewise, it is imperative to achieve greater compliance with the treatment in these patients, as well as to establish objectives adapted to reality, with individualized treatments and objectives and adjusted to the environment of these patients. |
|---|